RecruitingNot Applicable

The Effectiveness and Safety of Integrative Korean Medicine Treatment for Bell's Palsy

South Korea100 participantsStarted 2021-05-25

Plain-language summary

This is an observational study that evaluate the effectiveness and safety of Korean integrative treatments in patients with peripheral facial nerve palsy. Adulthood patients aged between 19 to 69 who were diagnosed with peripheral facial nerve palsy and receive Korean integrative treatments for facial palsy will be enrolled in the study and the change will be followed according to the Facial disability index (FDI) at the 3 month moment after baseline.

Who can participate

Age range19 Years – 69 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

✓. age of 19 to 69
✓. diagnosed with unilateral peripheral facial nerve palsy
✓. onset of facial palsy within 3 weeks or less.
✓. an individual who can provide written consent form to participate in the study.

Exclusion criteria

✕. diagnosed with central nervous system disease causing facial palsy
✕. secondary facial palsy after multiple sclerosis, tumor, cerebrovascular disease and temporal bone fracture.
✕. Ramsay-Hunt syndrome
✕. bilateral or recurrent facial nerve palsy.
✕. an individual who received any treatment that can have a significant effect on changes in facial paralysis within recent 2 month. (ie. facial nerve decompression surgery)
✕. already or planned to be pregnant or breast-feeding within the study period.
✕. uncontrolled diabetes mellitus within the last 3 months.
✕. within a month after participating any other facial palsy-related clinical trials, or planning to participate other clinical trials within 6 month.

What they're measuring

Facial disability index

Timeframe: week 14

Trial details

NCT IDNCT04905745

SponsorJaseng Medical Foundation

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2027-08-31

Contact for this trial

In-Hyuk Ha, KMD,Ph.D

+82-2-2222-2740 hanihata@gmail.com

View on ClinicalTrials.gov More Facial Paralysis, Peripheral trials